Amryt Pharma Share Discussion Threads

[bazworth] 03/5/2021 13:54

I reckon you’ll be thinking of yourself as an Ace Investor by the end of this year Paps, never give up!!

At least we think we understand what is going on with AMRYT!

[papillon] 02/5/2021 20:04

You're not using your little grey cells, ali47fish! The link is obvious! I should have sold my only shares, AMYT & GPM, last year and bought Bitcoin with the proceeds! Why didn't I? Because I'm stupid and a lousy investor! 😭🤬

[ali47fish] 02/5/2021 11:22

papi can't see the link to amyt!

[papillon] 02/5/2021 10:41

This is Money: Fund giant Ruffer slashes Bitcoin stake after Elon Musk tweets.


More on Bitcoin being seen as an alternative to gold. Is the Bitcoin bubble about to burst? I hope so, because I haven't got any! 🤣 Fingers crossed! 😁

[papillon] 30/4/2021 13:34

If you wanted excitement, alphabravo, then you picked the wrong share to invest in!
Why, oh why, didn't I sell all my AMYT shares a year ago and invest the proceeds in cryptos? Bitcoin and Ethereum would have made me lots of money, but I didn't understand them (far too old) and I'm a born loser that's why I'm invested in AMYT! 🤣

[alphabravo321] 30/4/2021 07:50

Get the finger out Amryt, this is a major snoozefest

[papillon] 29/4/2021 14:29

Well the recent high volume on Nasdaq reverted to below average yesterday and has died a death today! Just 8 ADS's traded so far, today, on Nasdaq! Simply amazing when you consider AMYT has a Mkt Cap of almost $500m and most of the shares are held in the USA!

[moorsie2] 28/4/2021 08:39

Great. That would be the most positive dynamic

[papillon] 28/4/2021 08:23

Have a look at the trades on Nasdaq, Moorsie2. Lots of relatively small trades rather than one "big seller". Almost all of the trades occurring early in the trading day. That looks to me like ex Novelion shareholders selling the AMYT ADS's they got via the Novelion liquidation.

[moorsie2] 28/4/2021 07:39

Clearly there is an overhang with this level of trades and no price movement.

Once the overhang clears though...

[bazworth] 27/4/2021 21:24

Some large trades reported over here too!

[moorsie2] 27/4/2021 21:07

71k trades on Nasdaq.

Must be a big seller

[papillon] 27/4/2021 14:03

Big volume again on Nasdaq so far today. Price of ADS's is going nowhere, however!
Ex holder's of Novelion who have received ADS's via the liquidator selling them?

[papillon] 26/4/2021 14:32

Really hotting up on Nasdaq. Now over 59k ADS's traded so far.

[papillon] 26/4/2021 14:21

Very big volume, so far today, on Nasdaq. Over 42k ADS's already traded. That's equivalent to over 200k AMYT shares.

[digadee] 23/4/2021 16:01

Some decent size trades on this side of the pond too

[papillon] 23/4/2021 15:16

Big volume today on Nasdaq. However the price hasn't moved

[bazworth] 20/4/2021 16:35

All very odd!!

[digadee] 20/4/2021 16:11

At the current price its as though all the positive rns in march never actually happened :-(Back to the rate prior to all the good news flow

[papillon] 15/4/2021 21:11

radar

Posts: 3,341

Price: 205.00

No Opinion

Someone Today 11:56
Bought 110,000 shares yesterday, usual pattern, lift is coming

>>>>>>>>>>>>>>>>>>>>>>>>>

And someone sold 225,000 shares valued at £450,000 earlier today (reporting delayed because of the size of the trade).

[bermudashorts] 12/4/2021 09:07

yep both of these events have been announced via RNS - see below

[diamondstar1] 12/4/2021 07:42

According to Epidermolysis Bullosa News - article on 9th April 2021 by Steve Bryson - Amryt has now completed FDA rolling submission for Filsuvez. In addition, Amryt’s filing for EU Marketing Authorisation has also been accepted by EMEA. All going in the right direction for Amryt.

[papillon] 07/4/2021 12:10

The following was posted today by, Bronxville, on the lse AMYT bb. Many thanks Bronxville.

Cannacord Genuity $40 targetToday 11:12
Amryt Pharma (AMYT) Received its Third Buy in a Row
By Ryan Adsit

Amryt Pharma (AMYT) Received its Third Buy in a Row After Leerink Partners and Maxim Group gave Amryt Pharma (NASDAQ: AMYT) a Buy rating last month, the company received another Buy, this time from Canaccord Genuity. Analyst Michelle Gilson maintained a Buy rating on Amryt Pharma yesterday and set a price target of $40.00. The company’s shares closed last Monday at $14.29.

According to TipRanks.com, Gilson is a 4-star analyst with an average return of 25.2% and a 51.4% success rate. Gilson covers the Healthcare sector, focusing on stocks such as BioMarin Pharmaceutical, Sigilon Therapeutics, and Travere Therapeutics.

Currently, the analyst consensus on Amryt Pharma is a Strong Buy with an average price target of $33.50, a 136.7% upside from current levels. In a report issued on March 31, Maxim Group also initiated coverage with a Buy rating on the stock with a $27.00 price target

[papillon] 07/4/2021 11:22

U.k. Spac is the name and SPC is it's epic code. I gave all the details in my post!!!!
Here's the advfn bb for the company.



The company was formerly called Mountfield Group.

[dingodollars] 07/4/2021 10:12

What's the name of the SPAC / SPV he's interested in?